Description of the molecular and clinical characteristics of the mucopolysaccharidosis type VII Iberian cohort
Abstract Background Mucopolysaccharidosis type VII (Sly syndrome) is an ultra-rare neurometabolic disorder caused by inherited deficiency of the lysosomal enzyme β-glucuronidase. Precise data regarding its epidemiology are scarce, but birth prevalence is estimated to vary from 0.02 to 0.24 per 100,0...
Main Authors: | Antonio Gónzalez-Meneses, Mercè Pineda, Anabela Bandeira, Patrícia Janeiro, María Ángeles Ruiz, Luisa Diogo, Ramón Cancho-Candela |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13023-021-02063-1 |
Similar Items
-
Pathway to diagnosis and burden of illness in mucopolysaccharidosis type VII – a European caregiver survey
by: Alexandra Morrison, et al.
Published: (2019-11-01) -
Individual heat map assessments demonstrate vestronidase alfa treatment response in a highly heterogeneous mucopolysaccharidosis VII study population
by: Christine Haller, et al.
Published: (2019-09-01) -
MPS VII – Extending the classical phenotype
by: A. Oldham, et al.
Published: (2022-12-01) -
Mucopolysaccharidosis VII in Brazil: natural history and clinical findings
by: Roberto Giugliani, et al.
Published: (2021-05-01) -
Prenatal mucopolysaccharidosis VII: A novel pathogenic variant identified in GUSB gene
by: Antonio Miguel Poyatos‐Andújar, et al.
Published: (2021-02-01)